Antisense modulation of the ICAM-1 phenotype of a model human bone marrow stromal cell line.
Publication/Presentation Date
10-10-1998
Abstract
Efficient stable gene transfer was achieved in a model human bone marrow stromal cell line, KM-102, using both Epstein-Barr virus and BK virus episomal expression vectors. Using this episomal expression system, effective overexpression and inhibition of ICAM-1 expression was achieved in stably transfected KM-102 cells by sense and antisense RNA gene transfer, respectively. Loss of surface ICAM-1 on antisense KM-102 transfectants did not significantly affect adhesion to LFA-1-bearing JY hematopoietic cells. However, KM-102 ICAM-1 overexpressors demonstrated enhanced binding (2.5-fold) to phorbol ester-treated, but not untreated, LFA-1-bearing JY cells. The increased binding could be blocked with anti-ICAM-1 antibodies. These findings suggest that while ICAM-1 is not required for basal adhesion between stromal and hematopoietic cells, stromal ICAM-1 may contribute to stromal:leukemic cellular interaction when bound to the phorbol ester-dependent high-avidity state of hematopoietic LFA-1.
Volume
244
Issue
1
First Page
239
Last Page
248
ISSN
0014-4827
Published In/Presented At
Weber, M. C., Groger, R. K., & Tykocinski, M. L. (1998). Antisense modulation of the ICAM-1 phenotype of a model human bone marrow stromal cell line. Experimental cell research, 244(1), 239–248. https://doi.org/10.1006/excr.1998.4192
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
9770366
Department(s)
Administration and Leadership
Document Type
Article